Crossmark

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

Crossref DOI link: https://doi.org/10.1016/j.bjid.2021.101647

Published Print: 2021-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Karlowsky, James A.

Kazmierczak, Krystyna M. https://orcid.org/0000-0001-6040-7804
Valente, Maria Lavínea Novis de Figueiredo

Luengas, Elkin Lemos https://orcid.org/0000-0002-2506-2000
Baudrit, Monique https://orcid.org/0000-0001-8593-3018
Quintana, Alvaro

Irani, Paurus

Stone, Gregory G. https://orcid.org/0000-0001-6115-2567
Sahm, Daniel F.
Funding

Funding for this research was provided by:

Pfizer
License Information

Text and Data Mining valid from 2021-11-01

Version of Record valid from 2021-10-27
More Information

This article is maintained by: Elsevier

Article Title: In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2021.101647

Content Type: article

Copyright: © 2021 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below